PREVIEW EDITION · THEFOREXINVESTOR.COM
The Forex ınvestorRESEARCH, REVIEWS & PERSPECTIVEGet the investor brief
Menu
THE INVESTOR EDITION
09 NOVEMBER 2026 · LAUNCH EDITION
COPY TRADING · PRODUCT REVIEW

eToro CopyTrader review

A straightforward copying interface does not make the copied portfolio straightforward.

Route
Copy trading
Cost basis
No extra copying fee; trading costs remain
Account / control
Copy controls inside eToro
Main question
Individual trader risk; regional terms

What the documentation establishes

CopyTrader replicates selected traders within eToro. Its product page describes controls to start and stop copying and add or remove allocated funds. The help page states that copying carries no additional fee, while applicable spreads, overnight CFD charges and other standard charges remain.

Documentation: eToro: CopyTrader product page ↗ · eToro: CopyTrader fees ↗

Our reading

Treat the copied trader as a portfolio. Check whether its return comes from currencies, equities, crypto or leveraged products before placing it in a forex comparison. A familiar interface is useful, but it cannot substitute for understanding the holdings.

What to watch

A platform risk label is a starting point. Look for concentration, long periods underwater and changes in leverage. Review the consequences of stopping a copy and retaining positions separately.

Before considering an allocation

  • Confirm the contracting entity and whether the relevant products are available where you live.
  • Read the selected trader’s current and historical exposure, not only its headline return.
  • Check the current fee schedule and stop-copy choices before committing.
Editorial conclusion
Worth examining as a copying platform; no individual trader or return is endorsed here.

Scope: no individual strategy return, customer withdrawal, licence permission or suitability assessment has been independently verified in this review. Product availability and terms must be confirmed for the exact entity and account. Links are source references, not tracked referral links.

Sources & review scope

Primary material checked 9 November 2026. Provider statements explain product mechanics; they are not independent confirmation of performance, permissions or withdrawals.